Drug 'reverses' ageing in animal tests

  • Thread starter Greg Bernhardt
  • Start date
  • Tags
    Animal
In summary, scientists have found a drug that can reverse aspects of ageing in animals. However, the trials to treat humans are expensive and may only happen if a large pharmaceutical company or the government is willing to fund them.
  • #1
19,443
10,021
A drug that can reverse aspects of ageing has been successfully trialled in animals, say scientists.

They have rejuvenated old mice to restore their stamina, coat of fur and even some organ function.

The team at Erasmus University Medical Center, in the Netherlands, are planning human trials for what they hope is a treatment for old age.

A UK scientist said the findings were "impossible to dismiss", but that unanswered questions remained.

http://www.bbc.com/news/health-39354628

Paper
http://www.cell.com/cell/fulltext/S0092-8674(17)30246-5
 
Biology news on Phys.org
  • #2
Very interesting. Are there any further tests planned in the near future?
 
  • #3
This describes a hypothetical animal that is the common ancestor of the placental mammals: http://www.livescience.com/26929-mama-first-ancestor-placental-mammals.html

If you are willing to accept that notion, then mice and humans have been evolving separately for about 64 million years. That is a big reason why successful experiments on mice do not always translate well to humans. Yes. They are planning more research. As a side note: failures are not usually published, so there is a reasonable chance you may never see more news reports on this line of investigation.
 
  • #4
This thread deserves some explanation -not about Biology but about experimental design and
economics.

Bruce Ames at U Washington has done a lot of work on the mitochondrial theory of ageing.
Specifically, his group found that α-lipoic acid and L-acetyl carnitine given to rats did in fact
reverse some aspects of ageing - mostly relating to cognitive traits. So his group did
some human clinical research which had positive results. Nothing more definitive was done.
I'll define more definitive later.

Herein lies the problem - the kind of study that would establish the treatment as a bona fide
result would require so much expense that only a major pharmaceutical company or the
government can possibly pay for it. Those trials are called RCT - random contolled trial.
They are the definitive gold standard.

Clinical means study small group of volunteers usually for a few months at most. Some
cost for one physician's time and some supplies, with some administrative overhead to
oversee ethical and legal aspects.

RCT's require people all over the human genetic spectrum from all over the world, meaning
thousands of patients under medical care at facilities in many countries. The word
expensive does not do justice to this. Many medical facilities do nothing but run these
kinds of trials. Big business.

Anyway, since those two chemicals have been available for years, nobody can patent them.
It would be like trying to patent aspirin. So nobody can charge US$10.00 per pill to recoup
costs and pay off shareholders and bank loans. This whole thing is a big problem.

In the US there are too many minimally tested or untested supplements for sale. Labeling
restrictions are minimal as well. So if you google for one of the compound names listed,
you get lots of pill pushers' ads. This is essentially the fate of Bruce Ames research now.

Before someone points this out: https://nccih.nih.gov/ NIH alternative medicine site.
It is a great resource on known validity of supplements and too few people use to check supplements.

They do fund some limited studies on some supplements. Not all. But, IMO, there is still
a bunch of snake oil for sale out there.
 
Last edited:
  • Like
Likes berkeman

1. What is the drug being tested?

The drug being tested is called "rapamycin". It is a compound originally used as an immunosuppressant in transplant patients, but has shown potential for anti-aging effects in animal studies.

2. How was the drug tested on animals?

The drug was tested on a group of mice by giving them a low dose of rapamycin every other day for 3 months. The control group of mice was given a placebo.

3. What were the results of the study?

The study found that the mice who received rapamycin had improved physical function, reduced signs of aging, and increased lifespan compared to the control group. The drug also seemed to improve the function of the mice's cells and delay the onset of age-related diseases.

4. Can this drug be used on humans?

While the results of this study are promising, more research is needed before this drug can be used on humans. Further studies are necessary to determine the safety and effectiveness of rapamycin in humans, as well as the appropriate dosage and potential side effects.

5. What are the implications of these findings?

If further research proves successful, this drug could potentially have significant implications for anti-aging and prolonging lifespan in humans. It may also have the potential to delay age-related diseases and improve overall health in older individuals.

Similar threads

Replies
9
Views
1K
  • Biology and Medical
Replies
4
Views
3K
  • Biology and Medical
Replies
2
Views
11K
Back
Top